Literature DB >> 22564834

Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del.

Hyojeong Yi1, Karan Kim, Kwang-Hwi Cho, Oksung Jung, Heenam Stanley Kim.   

Abstract

We describe a deletion mutation in a class A β-lactamase, PenA, of Burkholderia thailandensis that extended the substrate spectrum of the enzyme to include ceftazidime. Glu168del was located in a functional domain called the omega loop causing expansion of the space in the loop, which in turn increased flexibility at the active site. This deletion mutation represents a rare but significant alternative mechanical path to substrate spectrum extension in PenA besides more common substitution mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564834      PMCID: PMC3393396          DOI: 10.1128/AAC.00598-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Mol Biol       Date:  2002-06-28       Impact factor: 5.469

2.  Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.

Authors:  F M Thibault; E Hernandez; D R Vidal; M Girardet; J-D Cavallo
Journal:  J Antimicrob Chemother       Date:  2004-10-27       Impact factor: 5.790

Review 3.  Management of melioidosis.

Authors:  Vanaporn Wuthiekanun; Sharon J Peacock
Journal:  Expert Rev Anti Infect Ther       Date:  2006-06       Impact factor: 5.091

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus.

Authors:  S Petrella; D Clermont; I Casin; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

Authors:  P J Brett; D DeShazer; D E Woods
Journal:  Int J Syst Bacteriol       Date:  1998-01

7.  Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Authors:  I-Ching Sam; Kah Heng See; Savithri D Puthucheary
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  The early stage of bacterial genome-reductive evolution in the host.

Authors:  Han Song; Junghyun Hwang; Hyojeong Yi; Ricky L Ulrich; Yan Yu; William C Nierman; Heenam Stanley Kim
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates.

Authors:  Takeshi Saika; Intetsu Kobayashi; Miyuki Hasegawa; Minoru Nishida
Journal:  J Infect Chemother       Date:  2002-12       Impact factor: 2.211

10.  Investigating protein structural plasticity by surveying the consequence of an amino acid deletion from TEM-1 beta-lactamase.

Authors:  Alan M Simm; Amy J Baldwin; Kathy Busse; D Dafydd Jones
Journal:  FEBS Lett       Date:  2007-07-23       Impact factor: 4.124

View more
  11 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.

Authors:  Junghyun Hwang; Kwang-Hwi Cho; Han Song; Hyojeong Yi; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

3.  Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Elise T Zeiser; Julian A Gatta; John J LiPuma; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 4.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

Review 5.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

6.  Mutations in ArgS Arginine-tRNA Synthetase Confer Additional Antibiotic Tolerance Protection to Extended-Spectrum-β-Lactamase-Producing Burkholderia thailandensis.

Authors:  Hyojeong Yi; Jongwook Park; Kwang-Hwi Cho; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

7.  The tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum.

Authors:  Hyojeong Yi; Han Song; Junghyun Hwang; Karan Kim; William C Nierman; Heenam Stanley Kim
Journal:  PLoS Genet       Date:  2014-09-18       Impact factor: 5.917

8.  High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A β-lactamase, PenL.

Authors:  Hyojeong Yi; Jin Myung Choi; Junghyun Hwang; Fabio Prati; Thinh-Phat Cao; Sung Haeng Lee; Heenam Stanley Kim
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

Review 9.  Structural and Functional Aspects of Class A Carbapenemases.

Authors:  Thierry Naas; Laurent Dortet; Bogdan I Iorga
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

10.  A study of Rose Bengal against a 2-keto-3-deoxy-d-manno-octulosonate cytidylyltransferase as an antibiotic candidate.

Authors:  Suwon Kim; Seri Jo; Mi-Sun Kim; Dong Hae Shin
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.